课题基金 / 基金详情

The anti platelet agents treatment improves bladder function after outlet obstruction in rat

The anti platelet agents treatment improves bladder function after outlet obstruction in rat
抗血小板药物治疗可改善大鼠出口梗阻后的膀胱功能
批准号:
22890012
负责人:
MATSUMOTO Seiji
金额:
$1.71万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Research Activity Start-up
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2011

项目摘要

项目成果

MATSUMOTO Seiji的其他基金

相似基金

相关文献

中文摘要
翻译
[Aim]研究磷酸二酯酶3抑制剂(PDE 3 i)治疗是否可以改变膀胱出口梗阻(BOO)后的膀胱功能障碍。PDE 3 i是一种抗血小板药物,已被用于改善心脏和大脑的灌注。【材料与方法】将12周龄雌性SD大鼠分为5组,每组3只,分别为假手术组(1、2组)、BOO组(3-5组)、溶媒组(1、3组)、高剂量PDE 3 i组(2、51组)、低剂量PDE 3 i组(4组)。从手术当天开始,在饮食中给予PDE 3 i。在4周BOO时,切除膀胱并切成四个纵向条带用于等距器官浴测定。测定各组膀胱条对电场刺激(EFS)、卡巴胆碱和KCl的收缩反应。[结果]与第1、2组相比,第3-5组膀胱重量明显增加。PDE 3 i组的膀胱重量与媒介物组无显著差异。第3组对EFS、卡巴胆碱和KCl的收缩力约为第1组的20-40%。在BOO组中,PDE 3 i处理剂量依赖性的收缩力增加了BOO诱导的膀胱条收缩力的降低。[结论] PDE 3 i对4周BOO所致大鼠膀胱收缩功能障碍有明显的保护作用,但对膀胱重量的增加无明显影响。PDE 3 i可能是一个有用的保护,对收缩功能障碍的梗阻膀胱。
英文摘要
[Aim] To investigate whether bladder dysfunction after bladder outlet obstruction (BOO) could be altered by treatment with a phosphodiesterase 3 inhibitor (PDE3i). PDE3i, the antiplatelet agents, has been used to improve perfusion of the heart and brain.[Materials and methods] In all, 12-week-old female Sprague-Dawley rats were divided into five equal groups ; group 1 and 2, sham operated rats (each 3 rats); group 3-5, BOO rats (each 6 rats), and group 1 and 3 rats given vehicle ; group 2 and 51, rats given high dose PDE3i ; group 4 rats given low dose PDE3i, respectively. PDE3i was given within diet from the day of surgery. At 4-weeks BOO, the bladder was excised and dissected into four longitudinal strips for isometric organ-bath assay. Contractile responses of bladder strips to electrical field stimulation (EFS), carbachol and KCl was determined for each group.[Results] BOO induced a significant increase in bladder weight in group 3-5 compared with group 1 and 2. Bladder weights of PDE3i groups were not significantly different from vehicle groups. The contractile forces in response to EFS, carbachol and KCl in group 3 were about 20-40% of those in group 1. In BOO groups, the contractile forces in PDE3i treatment dose-dependency increase the BOO-induced reduction of contractile force in the bladder strips.[Conclusion] PDE3i has a small but significant protective effect on the contractile dysfunction induced by 4-weeks BOO in rats, although the increase in bladder mass was not altered. PDE3i could be a useful protection against contractile dysfunction of the obstructed bladder.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
排尿障害―最新診療動向.排尿障害(下部尿路機能障害)病態解説,医学のあゆみ
泌尿系统疾病 - 泌尿系统疾病(下尿路功能障碍)的病理学解释,医学史。
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [松本成史, 柿崎秀宏]
通讯作者: 柿崎秀宏
Causative significance of bladder blood flow in lower urinary taract symptoms
膀胱血流量与下尿路狭窄症状的病因意义
DOI: 10.1111/j.1442-2042.2011.02903.x
发表时间: 2012
期刊: Int J Urol
影响因子: 2.6
作者: [Matsumoto S, Kakizaki H]
通讯作者: Kakizaki H
下部尿路閉塞による膀胱機能変化に対するPDE5阻害剤の有用性とその機序
PDE5 抑制剂对下尿路梗阻引起的膀胱功能变化的作用和机制
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [松本成史, 柿崎秀宏, 松本成史]
通讯作者: 松本成史
特集:頻尿・尿失禁.メタボリック症候群と過活動膀胱
特点:尿频、尿失禁、代谢综合征和膀胱过度活动症。
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [松本成史, 柿崎秀宏]
通讯作者: 柿崎秀宏
Analysis of Hsk1 function in genome dynamics regulation by using new Hsk1-bypass mutants
The role of mast cells in the pathophysiology of chronic pelvic pain syndrome
  • 批准号:
    24590721
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.41万
  • 财政年份:
    2012
  • 负责人:
    MATSUMOTO Seiji
  • 依托单位:
Interleukin-6 (IL-6) receptor antibody therapy to malignant pleural mesothelioma
  • 批准号:
    23592077
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.41万
  • 财政年份:
    2011
  • 负责人:
    MATSUMOTO Seiji
  • 依托单位:
Evaluation of successful treatment of malignant pleural mesothelioma mouse model by intra-pleural new anti-drug (pemetrexed) administration
  • 批准号:
    18591567
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.33万
  • 财政年份:
    2006
  • 负责人:
    MATSUMOTO Seiji
  • 依托单位:
海外基金